Cloning and Functional Characterization of HDAC11, a Novel Member of the Human Histone Deacetylase Family
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
We have cloned and characterized a human cDNA that belongs to the histone deacetylase family, which we designate as HDAC11. The predicted HDAC11 amino acid sequence reveals an open reading frame of 347 residues with a corresponding molecular mass of 39 kDa. Sequence analyses of the putative HDAC11 protein indicate that it contains conserved residues in the catalytic core regions shared by both class I and II mammalian HDAC enzymes. Putative orthologues of HDAC11 exist in primate, mouse, Drosophila, and plant. Epitope-tagged HDAC11 protein expressed in mammalian cells displays histone deacetylase activity in vitro. Furthermore, HDAC11's enzymatic activity is inhibited by trapoxin, a known histone deacetylase inhibitor. Multiple tissue Northern blot and real-time PCR experiments show that the high expression level of HDAC11 transcripts is limited to kidney, heart, brain, skeletal muscle, and testis. Epitope-tagged HDAC11 protein localizes predominantly to the cell nucleus. Co-immunoprecipitation experiments indicate that HDAC11 may be present in protein complexes that also contain HDAC6. These results indicate that HDAC11 is a novel and unique member of the histone deacetylase family and it may have distinct physiological roles from those of the known HDACs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Two related classes of eukaryotic zinc-containing HDACs have been recognized based upon sequence similarity: class I (HDAC1, 2, 3, and 8) and class II (HDAC4, 5, 6, 7, 9, and 10) (Johnstone, 2002; Gao et al., 2002).”
From Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases (2004) · cites this paper as Gao et al., 2002
In the citing paper
“It has been shown to associate with HDAC6 (Gao et al., 2002; Cheng et al., 2014)”
From Histone deacetylase 11 is an ε-N-Myristoyllysine hydrolase (2018) · cites this paper as Gao et al., 2002
In the citing paper
“HDAC11 is a newly identified member of the HDAC family and thus far no known physiological function for HDAC11 has been demonstrated23.”
From The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance (2009) · cites this paper as [23]
Citations
Cites
Crystal structure of the nucleosome core particle at 2.8 Å resolution
Luger, K., Mäder, A. W., Richmond, R. K., Sargent, D. F., & Richmond, T. J. (1997) · Nature · doi:10.1038/38444 · Cited by 9,466
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
Roth, S. Y., Denu, J. M., & Allis, C. D. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.81 · Cited by 1,845
A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p
Taunton, J., Hassig, C. A., & Schreiber, S. L. (1996) · Science · doi:10.1126/science.272.5260.408 · Cited by 1,829
Histone acetylation and transcriptional regulatory mechanisms
Struhl, K. (1998) · Genes & Development · doi:10.1101/gad.12.5.599 · Cited by 1,815
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714
Nuclear Receptor Repression Mediated by a Complex Containing SMRT, mSin3A, and Histone Deacetylase
Nagy, L., Kao, H.-Y., Chakravarti, D., Lin, R. J., Hassig, C. A., Ayer, D. E., Schreiber, S. L., & Evans, R. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80218-4 · Cited by 1,230
Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation
Chen, L.-F., Fischle, W., Verdin, E., & Greene, W. C. (2001) · Science · doi:10.1126/science.1062374 · Cited by 1,222
Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation
McKinsey, T. A., Zhang, C.-L., Lu, J., & Olson, E. N. (2000) · Nature · doi:10.1038/35040593 · Cited by 1,052
Deacetylation of p53 modulates its effect on cell growth and apoptosis
Luo, J., Su, F., Chen, D., Shiloh, A., & Gu, W. (2000) · Nature · doi:10.1038/35042612 · Cited by 818
Research works printed but not linked: 2
- Van Lint, 1996, Gene Expr., 5, 245
- Fischle, 2001, Biochem. Cell Biol., 79, 337, 10.1139/o01-116 · DOI · Paper page
Cited by
Items 301–400 of 761
Fitzsimons, H. L. (2015) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2015.06.006 · Cited by 41
Chen, P., Huang, C., Meng, X., & Li, J. (2015) · Biochimie · doi:10.1016/j.biochi.2015.06.016 · Cited by 43
Pramanik, S. D., Halder, A. K., Mukherjee, U., Kumar, D., Dey, Y. N., & Mogana, R. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.948217 · Cited by 47
“Only HDAC 11 are found in Class IV (Gao et al., 2002).”
BackgroundDifferential molecular mechanistic behavior of HDACs in cancer progression
Singh, T., Kaur, P., Singh, P., Singh, S., & Munshi, A. (2022) · Medical Oncology · doi:10.1007/s12032-022-01770-4 · Cited by 46
You, D., Richardson, J. R., & Aleksunes, L. M. (2020) · Drug Metabolism and Disposition · doi:10.1124/dmd.119.089953 · Cited by 41
“Class IV contains a sole member, HDAC11, that is structurally different from both class I and II HDACs (Gao et al., 2002).”
BackgroundGomez-Sanchez, J. A., Patel, N., Martirena, F., Fazal, S. V., Mutschler, C., & Cabedo, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23062996 · Cited by 41
“HDAC11 has a ubiquitous subcellular location, but is predominantly confined to the nucleus [16,27].”
BackgroundEpigenetic Changes: Potential Therapeutic Targets
Kalebic, T. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb05982.x · Cited by 45
Abnormal histone acetylase and deacetylase expression and function in lung inflammation
Adcock, I. M., & Lee, K. Y. (2006) · Inflammation Research · doi:10.1007/s00011-006-0081-1 · Cited by 42
“Just as acetylation of histones is associated with gene induction, removal of acetyl groups by histone deacetylases (HDAC)s is generally associated with re-packing of chromatin and a lack of gene expression or gene silencing [10].”
BackgroundCombination Therapy and Dual-Target Inhibitors Based on LSD1: New Emerging Tools in Cancer Therapy
Shen, L., Wang, B., Wang, S., Ji, S., Fu, M., Wang, S.-W., Hou, W., Dai, X., & Liu, H. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c02133 · Cited by 41
Metal-dependent Deacetylases: Cancer and Epigenetic Regulators
López, J. E., Sullivan, E. D., & Fierke, C. A. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b01067 · Cited by 37
Histone deacetylases as targets in autoimmune and autoinflammatory diseases
Hamminger, P., Rîca, R., & Ellmeier, W. (2020) · Advances in immunology · doi:10.1016/bs.ai.2020.06.001 · Cited by 43
Designing HDAC-PROTACs: Lessons Learned So Far
Fischer, F., Avelar, L. A. A., Murray, L., & Kurz, T. (2021) · Future Medicinal Chemistry · doi:10.4155/fmc-2021-0206 · Cited by 38
Mechanisms of HDACs in cancer development
Zhang, Y., Wang, H., Zhan, Z., Gan, L., & Bai, O. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1529239 · Cited by 71
“HDAC11 is predominantly expressed in smooth muscle, heart, kidney and brain tissues (20), and is likely to be preferentially expressed in the gallbladder (21).”
Epigenetic regulation of hypoxia inducible factor in diseases and therapeutics
Nguyen, M. P., Lee, S., & Lee, Y. M. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0058-x · Cited by 40
Deacetylation of the DNA-binding Domain Regulates p53-mediated Apoptosis
Mellert, H. S., Stanek, T. J., Sykes, S. M., Rauscher, F. J., Schultz, D. C., & McMahon, S. B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.184663 · Cited by 38
Lysine Fatty Acylation: Regulatory Enzymes, Research Tools, and Biological Function
Komaniecki, G., & Lin, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.717503 · Cited by 39
“HDAC11 is reported to interact with HDAC6 so it is possible that changes in acetylation following HDAC11 modulation occur indirectly through HDAC6 or with the help of some unidentified cofactor or interacting partner that is lost in purification of HDAC11 for in vitro assays (Gao et al., 2002).”
BackgroundHow the flexibility of human histone deacetylases influences ligand binding: an overview
Deschamps, N., Simões‐Pires, C. A., Carrupt, P., & Nurisso, A. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.01.004 · Cited by 39
Gene expression regulation by heat-shock proteins: the cardinal roles of HSF1 and Hsp90
Mazaira, G. I., Daneri-Becerra, C., Zgajnar, N. R., Lotufo, C. M., & Galigniana, M. D. (2017) · Biochemical Society Transactions · doi:10.1042/bst20170335 · Cited by 39
Kulthinee, S., Yano, N., Zhuang, S., Wang, L., & Zhao, T. C. (2022) · Pathophysiology · doi:10.3390/pathophysiology29030038 · Cited by 39
Loss of HDAC11 accelerates skeletal muscle regeneration in mice
Núñez‐Álvarez, Y., Hurtado, E., Muñoz, M., García‐Tuñón, I., Rech, G. E., Pluvinet, R., Sumoy, L., Pendás, A. M., Peinado, M. A., & Suelves, M. (2020) · FEBS Journal · doi:10.1111/febs.15468 · Cited by 34
Yue, K., Qin, M., Huang, C., Chou, C. J., Jiang, Y., & Li, X. (2022) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2022.128797 · Cited by 36
Gene silencing by the thyroid hormone receptor
Eckey, M., Moehren, U., & Baniahmad, A. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.026 · Cited by 45
Oxidative Stress, Thiol Redox Signaling Methods in Epigenetics
Sundar, I. K., Caito, S. W., Yao, H., & Rahman, I. (2010) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(10)74013-1 · Cited by 38
HDAC6—An Emerging Target Against Chronic Myeloid Leukemia?
Losson, H., Schnekenburger, M., Dicato, M. A., & Diederich, M. F. (2020) · Cancers · doi:10.3390/cancers12020318 · Cited by 40
“HDAC11 Nucleus ND Transcriptional activation of interleukin 10 ND [90]”
MethodLedent, V., & Vervoort, M. (2006) · BMC Biology · doi:10.1186/1741-7007-4-24 · Cited by 36
“Recent phylogenetic studies [9] classify the non-sirtuin HDACs into three families: the well-known class 1 (which includes the human HDACs 1, 2, 3, and 8), class 2 (including the human HDACs 5, 6, 7, 9, and 10), and an additional class defined by the recently identified human HDAC 11 [10].”
Ong, B. X., Brunmeir, R., Zhang, Q., Xu, P., Idris, M., Liu, C., & Xu, F. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00095 · Cited by 32
“Lastly, class IV HDACs and HDAC10 are localized in the nucleus, even though it has also been reported that HDAC11 co-precipitates with HDAC6, which is found in the cytoplasm (40, 109).”
BackgroundDemyanenko, S. V., & Sharifulina, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157947 · Cited by 34
“HDAC6 could have nuclear localization and interoperate with HDAC11 [25], p300 [26], repressor complex LCoR and p65 subunit of nuclear factor-κB [27].”
BackgroundWen, Y., Zhang, X., Li, X., Tian, L., Shen, S., Ma, J., & Ai, F. (2022) · Journal of Cancer · doi:10.7150/jca.66914 · Cited by 36
“HDAC11, the sole member of HDAC class IV, was identified in 2002 as a new member of the zinc-dependent HDAC family [8].”
BackgroundInfluentialSirtuin Deacetylases as Therapeutic Targets in the Nervous System
Langley, B. C., & Sauve, A. A. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0214-5 · Cited by 34
“The last group is class IV, which contains the solitary member, HDAC 11 [8].”
Subcellular localization of rice histone deacetylases in organelles
Chung, P. J., Kim, Y. S., Park, S. H., Nahm, B. H., & Kim, J. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.06.003 · Cited by 37
“A new group of HDACs, the class IV group, has been distinguished from the class I group containing HDACs that are similar to AcuC [12,14].”
BackgroundInfluentialBaek, S. Y., Lee, J., Kim, T., Lee, H., Choi, H., Park, H., Koh, M., Kim, E., Jung, M. E., Iliopoulos, D., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115312 · Cited by 37
“HDAC11 is the only isoform in class IV; it is also the most recently identified and smallest HDAC enzyme [8].”
Baselious, F., Hilscher, S., Robaa, D., Barinka, C., Schutkowski, M., & Sippl, W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021358 · Cited by 32
“HDAC11, the sole member of class IV of the HDAC family, is the smallest member of the family and one of the least studied HDAC subtypes [3,4].”
BackgroundGeorge, S., & Palli, S. R. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00683 · Cited by 34
“HDAC11 first described in 2002 is a unique member class IV HDAC family since it is not homologous with RPD3 or HDA1 yeast enzymes (Gao et al., 2002).”
BackgroundThe Role of Epigenetics in the Chronic Sinusitis with Nasal Polyp
Liu, T., Sun, Y., & Bai, W. (2020) · Current Allergy and Asthma Reports · doi:10.1007/s11882-020-00976-8 · Cited by 34
Varricchio, L., Dell’Aversana, C., Nebbioso, A., Migliaccio, G., Altucci, L., Mai, A., Grazzini, G., Bieker, J. J., & Migliaccio, A. R. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.02.019 · Cited by 35
“The human HDAC family includes 18 isoforms classified on the basis of their sequence similarity to enzymes from Saccharomyces cerevisiae into class I (HDAC1, HDAC2, HDAC3 and HDAC8), class IIa (HDAC4, HDAC5, HDAC7 and HDAC9), class IIb (HDAC6 and HDAC10) (Bolden et al., 2006), class III (sirtuins) (Haigis et al., 2006…”
Inhibitors selective for HDAC6 in enzymes and cells
Gupta, P. K., Reid, R. C., Liu, L., Lucke, A. J., Broomfield, S., Andrews, M. R., Sweet, M. J., & Fairlie, D. P. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.09.100 · Cited by 33
Cadet, J., McCoy, M., & Jayanthi, S. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.345 · Cited by 31
“Interestingly, the role of multiple zinc-dependent HDACs in cocaine-induced behavioral effects was further supported by the demonstration that cocaine self-administration increased the expression of the class IV HDAC, HDAC11,38 which is highly expressed in the brain48 and shows great similarities to class I HDACs.49 C…”
BackgroundInfluentialEpigenetic regulation of motivated behaviors by histone deacetylase inhibitors
Elvir, L., Duclot, F., Wang, Z., & Kabbaj, M. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.09.030 · Cited by 36
Bai, P., Liu, Y., Yang, L., Ding, W., Mondal, P., Sang, N., Liu, G., Lü, X., Ho, T. T., Zhou, Y., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01491 · Cited by 32
Bonomi, R. E., Mukhopadhyay, U., Shavrin, A., Yeh, H.-H., Majhi, A., Dewage, S. W., Najjar, A. M., Lu, X., Cisneros, G. A., Tong, W. P., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133512 · Cited by 33
“Class IV HDACs is comprised of a single HDAC protein, HDAC11, which is considered to be separate from classes I and II due to its biological actions [7,8].”
BackgroundSui, L., Zhang, S., Huang, R., & Li, Z. (2020) · Cell Cycle · doi:10.1080/15384101.2019.1711315 · Cited by 32
“HDAC11 is reported to be associated with HDAC6 in both the cytoplasm and nuclear [17].”
BackgroundInfluentialOmonijo, O., Wongprayoon, P., Ladenheim, B., McCoy, M. T., Govitrapong, P., Jayanthi, S., & Cadet, J. L. (2014) · NeuroToxicology · doi:10.1016/j.neuro.2014.10.008 · Cited by 31
“HDAC11 contains residues within its catalytic domain that are shared by classes I and II HDACs (Gao et al, 2002).”
BackgroundMethodAn Overview of Naturally Occurring Histone Deacetylase Inhibitors
Kim, B., & Hong, J. (2014) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666141208105614 · Cited by 30
“HDAC11 was originally classified as a class I HDAC, but was recently placed in its own class because of low sequence homology to other HDACs [18, 21].”
BackgroundNutsford, A. N., Galvin, H. D., Ahmed, F., & Husain, M. (2018) · Cellular Microbiology · doi:10.1111/cmi.12989 · Cited by 33
“Because together with yeast HDAC—HOS3 and prokaryotic HDAC‐like proteins—acetoin utilisation proteins, and acetylpolyamine amidohydrolases, HDAC11 is most closely related to the common ancestral gene(s), from which all eukaryotic and prokaryotic HDACs have evolved (Gao et al., 2002).”
BackgroundInfluentialAn Overview of HDAC Inhibitors and their Synthetic Routes
Peng, X., Liao, G., Sun, P., Yu, Z., & Chen, J. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190227221507 · Cited by 31
Demyanenko, S. V., Berezhnaya, E. V., Neginskaya, M. A., Rodkin, S., Dzreyan, V., & Pitinova, M. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29266 · Cited by 31
The important role of histone deacetylases in modulating vascular physiology and arteriosclerosis
Zhao, T. C., Wang, Z., & Zhao, Y. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.04.020 · Cited by 30
Wang, Z., Zhao, Y., & Zhao, T. C. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220944128 · Cited by 37
“However, because HDAC11’s sequence has limited homology to class I and II HDACs, it has not yet been assigned to any of the other three classes.(39)”
BackgroundTrapoxin A Analogue as a Selective Nanomolar Inhibitor of HDAC11
Ho, T. T., Peng, C., Seto, E., & Lin, H. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.2c00840 · Cited by 30
Histone deacetylase inhibitors, anticancerous mechanism and therapy for gastrointestinal cancers
Fang, J. (2005) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.03807.x · Cited by 32
The regulatory role of c-MYC on HDAC2 and PcG expression in human multipotent stem cells
Bhandari, D. R., Seo, K., Jung, J., Kim, H., Yang, S., & Kang, K. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01144.x · Cited by 31
“cerevisiae and class IV consists of HDAC11 [25].”
Andreu‐Vieyra, C., & Berenson, J. R. (2014) · Therapeutic Advances in Hematology · doi:10.1177/2040620714552614 · Cited by 31
Sferra, R., Pompili, S., Festuccia, C., Marampon, F., Gravina, G. L., Ventura, L., Cesare, E. D., Cicchinelli, S., Gaudio, E., & Vetuschi, A. (2017) · European Journal of Histochemistry · doi:10.4081/ejh.2017.2732 · Cited by 31
The Theoretical Basis of Transcriptional Therapy of Cancer: Can It Be Put Into Practice?
Melnick, A. M., Adelson, K. B., & Licht, J. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.14.498 · Cited by 29
Histone Deacetylases and Cardiometabolic Diseases
Yiew, K. H., Chatterjee, T. K., Hui, D. Y., & Weintraub, N. L. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.305046 · Cited by 32
Tago, T., & Toyohara, J. (2018) · Molecules · doi:10.3390/molecules23020300 · Cited by 28
“HDAC11, the only class IV HDAC, contains conserved residues in the catalytic core regions shared by both class I and II HDACs [22].”
BackgroundHDAC as a Therapeutic Target for Treatment of Endometrial Cancers
Ren, J., Zhang, J., Cai, H., Li, Y., Zhang, Y., Zhang, X., Zhao, D., Li, Z., Ma, H., Wang, J., et al. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990528 · Cited by 28
Chen, L., Lai, Y., Li, T., Nyunoya, T., & Zou, C. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00142.2019 · Cited by 29
Unexpected Roles for Deacetylation in Interferon- and Cytokine-Induced Transcription
Nusinzon, I., & Horvath, C. M. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.745 · Cited by 32
Sirtuins, a key regulator of ageing and age-related neurodegenerative diseases
Bhatt, V., & Tiwari, A. K. (2023) · International Journal of Neuroscience · doi:10.1080/00207454.2022.2057849 · Cited by 28
“The HDAC11 protein is also available in the fly, mouse, and other organisms but not in the yeast and nematodes [4, 5, 7, 9].”
BackgroundMostofa, A., Distler, A., Meads, M. B., Sahakian, E., Powers, J. J., Achille, A., Noyes, D., Wright, G., Fang, B., Izumi, V., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.151713 · Cited by 27
“Both constructs were sequenced and were identical to the HDAC11 sequence originally reported by Gao et al. (60).”
Breaking the Silence: Regulation of HIV Transcription and Latency on the Road to a Cure
Duggan, N. N., Dragic, T., Chanda, S. K., & Pache, L. (2023) · Viruses · doi:10.3390/v15122435 · Cited by 32
Disruption to schizophrenia-associated gene Fez1 in the hippocampus of HDAC11 knockout mice
Bryant, D., Landles, C., Papadopoulou, A. S., Benjamin, A. C., Duckworth, J. K., Rosahl, T. W., Benn, C., & Bates, G. P. (2017) · Scientific Reports · doi:10.1038/s41598-017-11630-1 · Cited by 31
Comparative Modeling and Benchmarking Data Sets for Human Histone Deacetylases and Sirtuin Families
Xia, J., Tilahun, E. L., Kebede, E. H., Reid, T.-E. R., Zhang, L., & Wang, X. S. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/ci5005515 · Cited by 28
Ahmad, M., Hamid, A., Hussain, A., Majeed, R., Qurishi, Y., Bhat, J. A., Najar, R. A., Qazi, A. K., Zargar, M. A., Singh, S. K., et al. (2012) · DNA and Cell Biology · doi:10.1089/dna.2011.1575 · Cited by 30
Angiogenic Factor With G Patch and FHA Domains 1 Is a Novel Regulator of Vascular Injury
Zhou, B., Zeng, S., Li, N., Yu, L., Yang, G., Yang, Y., Zhang, X., Fang, M., Xia, J., & Xu, Y. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.308992 · Cited by 27
“in the muscle.(19) HDAC11 has been implicated in the regulation of immune response(20,21) and carcinogenesis,(22,23) and our data expand the territory of pathophysiological processes HDAC11 can potentially influence.”
BackgroundIan, M. T. (2006) · Frontiers in bioscience · doi:10.2741/2079 · Cited by 29
“Hypoacetylation of histones associates with transcriptional silence, and several transcriptional repressors and co-repressors have been identified which have (or recruit) HDAC activity (9-11).”
BackgroundHDAC11: A novel target for improved cancer therapy
Liu, Y., Tong, X., Hu, W., & Chen, D. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115418 · Cited by 34
Wang, X., Li, N., Zheng, M., Yu, Y., & Zhang, S. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101815 · Cited by 26
“Class IV includes only one member, HDAC11, which is localized in the nucleus, but in activity assays, HDAC11 co-precipitates with cytoplasmically localized HDAC6 [90,91].”
BackgroundEvolutionary relationships among protein lysine deacetylases of parasites causing neglected diseases
Scholte, L., Mourão, M. D. M., Pais, F. S.-M., Melesina, J., Robaa, D., Volpini, Â. C., Sippl, W., Pierce, R. J., Oliveira, G., & Nahum, L. A. (2017) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2017.05.011 · Cited by 31
Lozada, E., Andrysík, Z., Yin, M., Redilla, N., Rice, K., & Stambrook, P. J. (2016) · Oncotarget · doi:10.18632/oncotarget.7966 · Cited by 29
“The most recently identified and least well studied deacetylase is the Class IV member, HDAC11 [34].”
Advances in the Design and Development of PROTAC-mediated HDAC Degradation
Rodrigues, D. A., Roe, A. J., Griffith, D. M., & Chonghaile, T. N. (2021) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026621666211015092047 · Cited by 28
PROTAC chemical probes for histone deacetylase enzymes
Patel, U., Smalley, J. P., & Hodgkinson, J. T. (2023) · RSC Chemical Biology · doi:10.1039/d3cb00105a · Cited by 26
Kinugasa, F., Nagatomi, I., Nakanishi, T., Noto, T., Mori, H., Matsuoka, H., Sudo, Y., & Mutoh, S. (2009) · Transplant Immunology · doi:10.1016/j.trim.2009.04.006 · Cited by 25
Pandey, P., Daghma, D. E. S., Houben, A., Kumlehn, J., Melzer, M., & Rutten, T. L. M. (2017) · Plant Reproduction · doi:10.1007/s00497-017-0302-5 · Cited by 26
Recent Advances in Medicinal Chemistry of Histone Deacetylase Inhibitors
Weinmann, H., & Ottow, E. (2004) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(04)39015-9 · Cited by 25
Graziani, G., Tentori, L., Portarena, I., Vergati, M., & Navarra, P. (2003) · Endocrinology · doi:10.1210/en.2002-0180 · Cited by 23
Drug Discovery for Histone Deacetylase Inhibition: Past, Present and Future of Zinc-Binding Groups
Pires, G. S., Tolomeu, H. V., Rodrigues, D. A., Lima, L. M., Fraga, C. A. M., & Pinheiro, P. D. S. M. (2025) · Pharmaceuticals · doi:10.3390/ph18040577 · Cited by 32
“It is expressed particularly in the kidneys, brain, skeletal muscle and heart, and is structurally related to classes I and II [41].”
Myelodysplastic Syndrome and Histone Deacetylase Inhibitors: “To Be or Not to Be Acetylated”?
Stintzing, S., Kemmerling, R., Kiesslich, T., Alinger, B., Ocker, M., & Neureiter, D. (2011) · BioMed Research International · doi:10.1155/2011/214143 · Cited by 28
“Additionally, HDAC11 represents a separate class (class IV) of HDACs, since HDAC11 is structurally related to both, class I and II HDACs [88].”
BackgroundInfluentialHistone deacetylase (HDACs) inhibitors: Clinical applications
Shanmukha, K. D., Paluvai, H., Lomada, S. K., Gokara, M., & Kalangi, S. K. (2023) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2023.02.011 · Cited by 29
Singh, P., Cho, K., Padi, S. K. R., Yu, J., Haldar, M., Mandal, T., Yan, C., Cook, G. R., Guo, B., Mallik, S., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.600627 · Cited by 25
“The class IV HDAC has a single member (HDAC11) and is unrelated to other HDAC isozymes (8).”
BackgroundPolydactyly in Mice Lacking HDAC9/HDRP
Morrison, B. E., & D’Mello, S. R. (2008) · Experimental Biology and Medicine · doi:10.3181/0802-rm-48 · Cited by 25
“The fourth class of HDACs contains a single member, HDAC11, which localizes predominantly to the nucleus (8).”
BackgroundThe Impact of Protein Acetylation/Deacetylation on Systemic Lupus Erythematosus
Ren, J., Panther, E. J., Liao, X., Grammer, A. C., Lipsky, P. E., & Reilly, C. M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124007 · Cited by 27
“HDAC11 is the only class IV HDAC discovered to date, but its function is not well delineated [90,91].”
BackgroundZhou, H., Jiang, S., Chen, J., Ren, X., Jin, J., & Su, S. B. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.06.019 · Cited by 25
“Breaking the equilibrium of histone acetylation and deacetylation mediated by HDACs and histone acetylases (HATs) may cause tumor and neovascularization (Cress WD, 2000; Gao et al., 2002).”
BackgroundYoung, D. A., Billingham, O., Sampieri, C. L., Edwards, D. R., & Clark, I. M. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.04622.x · Cited by 26
Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia
Maharaj, K. K., Powers, J. J., Achille, A. N., Deng, S., Fonseca, R., Pabón-Saldaña, M., Quayle, S. N., Jones, S. S., Villagra, A., Sotomayor, E. M., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018020065 · Cited by 23
Critical review of non‐histone human substrates of metal‐dependent lysine deacetylases
Toro, T. B., & Watt, T. J. (2020) · The FASEB Journal · doi:10.1096/fj.202001301rr · Cited by 24
Histone deacetylase‑2: A potential regulator and therapeutic target in liver disease (Review)
Liu, Y.-R., Wang, J., Huang, Z., Chen, R.-N., Cao, X., Zhu, D., Yu, H., Wang, X., Zhou, H.-Y., Xia, Q., et al. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4964 · Cited by 24
Role of Histone Deacetylase 6 and Histone Deacetylase 6 Inhibition in Colorectal Cancer
Vuletić, A. M., Martinović, K. M., & Spasić, J. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics16010054 · Cited by 24
Kinugasa, F., Yamada, T., Noto, T., Matsuoka, H., Mori, H., Sudo, Y., & Mutoh, S. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.1723 · Cited by 23
Jha, P. K., Khan, M. I., Mishra, A., Das, P. K., & Sinha, K. K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177372 · Cited by 23
Zhang, J.-L., Yuan, X.-B., Chen, S., Chen, H., Xu, N., Xue, W.-H., Fu, S., Zhang, C., & Xu, H. (2018) · Open Biology · doi:10.1098/rsob.180158 · Cited by 25
Functional Analysis of HDACs in Tumorigenesis
Hadley, M. M., Noonepalle, S. K. R., Banik, D., & Villagra, A. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9434-2_17 · Cited by 26
Demyanenko, S. V., Dzreyan, V., & Uzdensky, A. B. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.06.010 · Cited by 23
Histone Acetylation and Deacetylation
Fass, D. M., Kemp, M. M., Schroeder, F. A., Wagner, F. F., Wang, Q., & Holson, E. B. (2012) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.201100036 · Cited by 23
The development and potential clinical utility of biomarkers for HDAC inhibitors
Shi, B., & Xu, W. (2013) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2013.v7.4.129 · Cited by 26
“Class IV HDACs (only comprising HDAC-11), which localize in the nucleus, exhibit properties of both Class I and Class II HDACs (13), but the overall sequence similarity is too low to be placed in either class (14).”
BackgroundHuang, R., Sui, L., Fu, C., Zhai, Y., Dai, X., Zhang, S., & Li, Z. (2021) · Aging · doi:10.18632/aging.202697 · Cited by 23
“More importantly, HDAC11 has been reported to be associated with HDAC6 in both the nucleus and cytoplasm [11].”
BackgroundInfluentialRole of Histone Deacetylases in T-Cell Development and Function
Pieniawska, M., & Iżykowska, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147828 · Cited by 25
“It is mainly localized in the nucleus, but it could be also detected in the cytoplasm, for example, in resting CD4+ T-cells [114,115].”
BackgroundWen, L., Wang, J., WANG, Y., & Chen, F. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2236 · Cited by 22
A Decade of the Human Genome Sequence—How Does the Medicinal Chemist Benefit?
Brunschweiger, A., & Hall, J. (2011) · ChemMedChem · doi:10.1002/cmdc.201100498 · Cited by 23
Metadata
- Authors
- Gao, L., Cueto, M. A., Asselbergs, F., & Atadja, P.
- Affiliations
- Novartis (United States) (US)
- Corresponding author
- Atadja, Peter
- ORCID
- Gao, Lin
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-07
- Volume
- 277
- Issue
- 28
- Pages
- 25748-25755
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2070089404
- Cited by
- 744
- References
- 43
- Citations by year
- 2026: 27 · 2025: 28 · 2024: 32 · 2023: 36 · 2022: 31 · 2021: 33 · 2020: 43 · 2019: 26 · 2018: 30 · 2017: 36 · 2016: 30 · 2015: 41 · 2014: 34 · 2013: 30 · 2012: 37
- FWCI
- 8.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6687 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- HDAC11, histone deacetylase, cDNA cloning, histone deacetylase activity, tissue expression, nuclear localization, protein complexes, evolutionary conservation
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Cloning, Molecular, Histone Deacetylases, Humans, Molecular Sequence Data, Nuclear Proteins, RNA, Messenger, Sequence Homology, Amino Acid, DNA, Complementary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.